Markston International LLC decreased its stake in shares of Aetna Inc. (NYSE:AET) by 5.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 224,120 shares of the company’s stock after selling 13,823 shares during the period. Aetna makes up approximately 3.3% of Markston International LLC’s holdings, making the stock its 2nd largest position. Markston International LLC owned about 0.07% of Aetna worth $34,029,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in AET. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Aetna by 31.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 52,641 shares of the company’s stock valued at $6,713,000 after buying an additional 12,648 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Aetna by 0.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 282,165 shares of the company’s stock valued at $35,990,000 after buying an additional 875 shares in the last quarter. Toronto Dominion Bank boosted its stake in shares of Aetna by 57.0% in the first quarter. Toronto Dominion Bank now owns 95,608 shares of the company’s stock valued at $12,194,000 after buying an additional 34,719 shares in the last quarter. Boston Advisors LLC boosted its stake in shares of Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock valued at $371,000 after buying an additional 500 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in shares of Aetna by 89.4% in the first quarter. SG Americas Securities LLC now owns 171,778 shares of the company’s stock valued at $21,910,000 after buying an additional 81,077 shares in the last quarter. 91.69% of the stock is owned by institutional investors.

Aetna Inc. (NYSE:AET) opened at 156.10 on Friday. Aetna Inc. has a one year low of $104.59 and a one year high of $161.69. The firm has a market capitalization of $51.84 billion, a price-to-earnings ratio of 34.65 and a beta of 0.54. The stock has a 50 day moving average of $155.24 and a 200 day moving average of $141.63.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the prior year, the company posted $2.21 earnings per share. The firm’s revenue was down 2.7% on a year-over-year basis. Analysts forecast that Aetna Inc. will post $9.55 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/27/markston-international-llc-decreases-position-in-aetna-inc-aet.html.

Several analysts recently issued reports on AET shares. Bank of America Corporation reaffirmed a “buy” rating and set a $168.00 price objective (up previously from $160.00) on shares of Aetna in a research note on Wednesday, May 17th. Morgan Stanley started coverage on shares of Aetna in a research note on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price objective for the company. Jefferies Group LLC reaffirmed a “hold” rating and set a $163.00 price objective (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a research note on Tuesday, July 4th. Finally, Deutsche Bank AG upped their price objective on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Seven analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $157.99.

In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,008,606.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.90% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.